Candel Therapeutics Inc (CADL)

Healthcare Pharmaceuticals & Medical Research Biotechnology & Medical Research

Track

Stock chart
Ticker: CADL Exchange: NMS


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Earnings
Earnings
 
Value bought

Past 90 days

 
Value sold

Past 90 days

 
Net insiders buying

Past 90 days

 
Trades (buy and sell)

Past 90 days

Abbreviations B: Buy, S: Sell, PP: Planned purchase, PS: Planned sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2025-03-20 2025-03-19 PS Planned sale

Tak Paul Peter

Chief Executive Officer

Executive Director
400 -0.2%
9.00
USD 3,601 		400 -0.2% 9.00 USD 3,601
2025-03-20 2025-03-18 PS Planned sale

Nichols William Garrett

Chief Medical Officer

Officer
45,316 -46.3%
8.76
USD 396,995 		45,316 -46.3% 8.76 USD 396,995
2025-03-20 2025-03-18 PS Planned sale

Barone Francesca

Chief Scientific Officer

Officer
32,146 -25.0%
8.76
USD 281,673 		32,146 -25.0% 8.76 USD 281,673
2025-03-20 2025-03-18 PS Planned sale

Tak Paul Peter

Chief Executive Officer

Executive Director
25,772 -10.2%
8.77
USD 226,023 		25,772 -10.2% 8.77 USD 226,023
2025-03-19 2025-03-17 PS Planned sale

Tyagarajan Seshu

Chief Technology Officer

Officer
31,278 -26.8%
8.82
USD 275,947 		31,278 -26.8% 8.82 USD 275,947
2025-03-19 2025-03-17 PS Planned sale

Schoch Charles

See Remarks

Officer
5,000 -11.6%
8.83
USD 44,169 		5,000 -11.6% 8.83 USD 44,169
2025-01-17 2025-01-15 S Sale

Tyagarajan Seshu

Chief Technology Officer

Officer
14,322 -12.9%
7.23
USD 103,476 		14,322 -12.9% 7.23 USD 103,476
2025-01-17 2025-01-15 S Sale

Schoch Charles

See Remarks

Officer
9,511 -18.1%
7.23
USD 68,717 		9,511 -18.1% 7.23 USD 68,717
2025-01-17 2025-01-15 S Sale

Tak Paul Peter

Chief Executive Officer

Executive Director
21,704 -7.9%
7.23
USD 156,811 		21,704 -7.9% 7.23 USD 156,811
2025-01-17 2025-01-15 S Sale

Barone Francesca

Chief Scientific Officer

Officer
13,534 -10.9%
7.23
USD 97,783 		13,534 -10.9% 7.23 USD 97,783
2025-01-17 2025-01-15 S Sale

Nichols William Garrett

Chief Medical Officer

Officer
10,428 -11.6%
7.23
USD 75,342 		10,428 -11.6% 7.23 USD 75,342
2025-01-10 2025-01-08 S Sale

Tak Paul Peter

Chief Executive Officer

Executive Director
21,172 -7.2%
8.22
USD 173,996 		21,172 -7.2% 8.22 USD 173,996
2025-01-10 2025-01-08 S Sale

Schoch Charles

See Remarks

Officer
9,971 -15.9%
8.22
USD 81,944 		9,971 -15.9% 8.22 USD 81,944
2025-01-10 2025-01-08 S Sale

Barone Francesca

Chief Scientific Officer

Officer
13,673 -9.9%
8.22
USD 112,367 		13,673 -9.9% 8.22 USD 112,367
2025-01-10 2025-01-08 S Sale

Tyagarajan Seshu

Chief Technology Officer

Officer
14,545 -11.6%
8.22
USD 119,534 		14,545 -11.6% 8.22 USD 119,534
2025-01-10 2025-01-08 S Sale

Nichols William Garrett

Chief Medical Officer

Officer
10,799 -10.7%
8.22
USD 88,749 		10,799 -10.7% 8.22 USD 88,749
2024-12-18 2024-12-16 B Purchase

Manning Paul B

Non-Executive Director
750,000 +135.4%
6.00
USD 4,500,000 		750,000 +135.4% 6.00 USD 4,500,000
2024-12-18 2024-12-16 B Purchase

Manning Paul B

Non-Executive Director
500,000 +77.8%
6.00
USD 3,000,000 		500,000 +77.8% 6.00 USD 3,000,000
2024-12-03 2024-11-29 S Sale

Barone Francesca

Chief Scientific Officer

Officer
22,081 -13.8%
4.56
USD 100,592 		22,081 -13.8% 4.56 USD 100,592
2024-12-03 2024-11-29 S Sale

Nichols William Garrett

Chief Medical Officer

Officer
13,935 -12.2%
4.56
USD 63,482 		13,935 -12.2% 4.56 USD 63,482
2024-12-03 2024-11-29 S Sale

Tak Paul Peter

Chief Executive Officer

Executive Director
48,847 -14.2%
4.56
USD 222,527 		48,847 -14.2% 4.56 USD 222,527
2024-12-03 2024-11-29 S Sale

Tyagarajan Seshu

Chief Technology Officer

Officer
20,392 -14.0%
4.56
USD 92,898 		20,392 -14.0% 4.56 USD 92,898
2024-10-15 2024-10-15 S Sale

Aguilar-Cordova Estuardo

Large shareholder
10,412 -1.1%
6.03
USD 62,784 		10,412 -1.1% 6.03 USD 62,784
2024-10-15 2024-10-14 S Sale

Aguilar-Cordova Estuardo

Large shareholder
15,000 -1.6%
6.02
USD 90,300 		15,000 -1.6% 6.02 USD 90,300
2024-10-15 2024-10-11 S Sale

Aguilar-Cordova Estuardo

Large shareholder
15,000 -1.6%
6.05
USD 90,750 		15,000 -1.6% 6.05 USD 90,750
2024-10-03 2024-10-03 S Sale

Aguilar-Cordova Estuardo

Large shareholder
1,800 -0.2%
6.85
USD 12,330 		1,800 -0.2% 6.85 USD 12,330
2024-10-03 2024-10-02 S Sale

Aguilar-Cordova Estuardo

Large shareholder
26,988 -2.7%
6.92
USD 186,757 		26,988 -2.7% 6.92 USD 186,757
2024-07-19 2024-07-17 S Sale

Barone Francesca

Chief Scientific Officer

Officer
14,051 -8.1%
6.47
USD 90,947 		14,051 -8.1% 6.47 USD 90,947
2024-07-19 2024-07-17 S Sale

Schoch Charles

See Remarks

Officer
9,884 -13.7%
6.47
USD 63,975 		9,884 -13.7% 6.47 USD 63,975
2024-07-19 2024-07-17 S Sale

Tak Paul Peter

Chief Executive Officer

Executive Director
22,528 -6.4%
6.47
USD 145,815 		22,528 -6.4% 6.47 USD 145,815
2024-07-19 2024-07-17 S Sale

Tyagarajan Seshu

Chief Technology Officer

Officer
14,851 -9.2%
6.47
USD 96,125 		14,851 -9.2% 6.47 USD 96,125
2024-07-19 2024-07-17 S Sale

Nichols William Garrett

Chief Medical Officer

Officer
10,875 -8.7%
6.47
USD 70,390 		10,875 -8.7% 6.47 USD 70,390
2024-07-15 2024-07-11 S Sale

Tyagarajan Seshu

Chief Technology Officer

Officer
13,330 -7.7%
5.97
USD 79,625 		13,330 -7.7% 5.97 USD 79,625
2024-07-15 2024-07-11 S Sale

Tak Paul Peter

Chief Executive Officer

Executive Director
20,293 -5.4%
5.97
USD 121,218 		20,293 -5.4% 5.97 USD 121,218
2024-07-15 2024-07-11 S Sale

Nichols William Garrett

Chief Medical Officer

Officer
9,769 -7.2%
5.97
USD 58,354 		9,769 -7.2% 5.97 USD 58,354
2024-07-15 2024-07-11 S Sale

Schoch Charles

See Remarks

Officer
8,897 -10.9%
5.97
USD 53,145 		8,897 -10.9% 5.97 USD 53,145
2024-07-15 2024-07-11 S Sale

Barone Francesca

Chief Scientific Officer

Officer
12,645 -6.8%
5.97
USD 75,534 		12,645 -6.8% 5.97 USD 75,534
2022-12-12 2022-12-09 B Purchase

Tak Paul Peter

Chief Executive Officer

Executive Director
12,935 +46.1%
1.92
USD 24,835 		12,935 +46.1% 1.92 USD 24,835
2022-12-12 2022-12-09 B Purchase

Amello Jason

Chief Financial Officer

Officer
2,468 +79.6%
1.93
USD 4,763 		2,468 +79.6% 1.93 USD 4,763
2022-12-12 2022-12-09 B Purchase

Tyagarajan Seshu

Chief Technology Officer

Officer
10,358 +345.3%
1.93
USD 19,991 		10,358 +345.3% 1.93 USD 19,991
2022-12-12 2022-12-09 B Purchase

Martell Christopher

Non-Executive Director
23,950 +18.7%
1.92
USD 45,984 		23,950 +18.7% 1.92 USD 45,984
2022-12-12 2022-12-09 B Purchase

PAPA JOSEPH C

Non-Executive Director
35,018 +1161.8%
1.94
USD 67,935 		35,018 +1161.8% 1.94 USD 67,935
2022-12-12 2022-12-08 B Purchase

Tak Paul Peter

Chief Executive Officer

Executive Director
3,050 +12.2%
1.70
USD 5,185 		3,050 +12.2% 1.70 USD 5,185
2022-12-12 2022-12-08 B Purchase

Amello Jason

Chief Financial Officer

Officer
3,100 +inf%
1.69
USD 5,239 		3,100 +inf% 1.69 USD 5,239
2022-12-12 2022-12-08 B Purchase

Barone Francesca

Chief Scientific Officer

Officer
1,238 +82.5%
1.61
USD 1,993 		1,238 +82.5% 1.61 USD 1,993
2022-12-12 2022-12-08 B Purchase

Tyagarajan Seshu

Chief Technology Officer

Officer
3,000 +inf%
1.69
USD 5,070 		3,000 +inf% 1.69 USD 5,070
2022-12-12 2022-12-08 B Purchase

Martell Christopher

Non-Executive Director
3,050 +2.4%
1.68
USD 5,124 		3,050 +2.4% 1.68 USD 5,124
2022-12-12 2022-12-08 B Purchase

PAPA JOSEPH C

Non-Executive Director
3,014 +inf%
1.70
USD 5,124 		3,014 +inf% 1.70 USD 5,124
2021-08-02 2021-07-29 B Purchase

Martell Christopher

Non-Executive Director
125,000 +inf%
8.00
USD 1,000,000 		125,000 +inf% 8.00 USD 1,000,000
// ... existing code ... // ... rest of the file ...